31 – 40 of 207
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers : a longitudinal cohort study
- Contribution to journal › Article
-
Mark
Plasma p-tau immunoassays in clinical research for Alzheimer's disease
- Contribution to journal › Scientific review
-
Mark
Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia
- Contribution to journal › Article
-
Mark
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta
- Contribution to journal › Article
-
Mark
Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome
- Contribution to journal › Article
- 2024
-
Mark
Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders
- Contribution to journal › Article
-
Mark
Cerebrovascular disease is associated with Alzheimer's plasma biomarker concentrations in adults with Down syndrome
- Contribution to journal › Article
-
Mark
Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer’s disease: a pilot study
- Contribution to journal › Article
-
Mark
Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies
- Contribution to journal › Article
-
Mark
Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment
- Contribution to journal › Article
